Azevan Pharmaceuticals Inc.

Bethlehem, PA

UEI
VHSKTKSAY2S1
CAGE
473U1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Ben Franklin Techventures, 116 Research Dr, Bethlehem, PA 18015, USA
Website
azevan.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Azevan Pharmaceuticals Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A phase 2 clinical trial of SRX246 in fragile x syndrome (FXS) Grant · HT94252510521 Defense Health Agency $7,742,222
A new drug to prevent the effects of mild TBI/concussion Grant · HT94252410617 Defense Health Agency $1,973,398
A new drug for the treatment of traumatic brain injury Grant · R43NS110343 National Institute of Neurological Disorders and Stroke $501,472
A POC clinical trial for ptsd with a first-in-class vasopressin 1A receptor antagonist Grant · W81XWH1510645 Medical Command $2,009,434
Advancing SRX246 to commericialization Grant · R44NS090616 National Institute of Neurological Disorders and Stroke $3,190,881

Quick answers

What is Azevan Pharmaceuticals Inc.'s UEI?

Azevan Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is VHSKTKSAY2S1.

What is Azevan Pharmaceuticals Inc.'s CAGE code?

Azevan Pharmaceuticals Inc.'s CAGE code is 473U1.

Where is Azevan Pharmaceuticals Inc. located?

Azevan Pharmaceuticals Inc.'s physical address in SAM.gov is Ben Franklin Techventures, 116 Research Dr, Bethlehem, PA 18015, USA.

Is Azevan Pharmaceuticals Inc. registered in SAM.gov?

Yes. Azevan Pharmaceuticals Inc.'s SAM.gov registration is active through September 9, 2027.

What is Azevan Pharmaceuticals Inc.'s most recent federal award?

Azevan Pharmaceuticals Inc.'s most recent federal grant award is A phase 2 clinical trial of SRX246 in fragile x syndrome (FXS) (HT94252510521), from Defense Health Agency, on July 1, 2025.

On GovTribe

See Azevan Pharmaceuticals Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login